RESUMEN
Introduction: Inequalities in the health field are caused by the differences in the social and economic conditions, that influence the disease risk and the measures taken to treat the disease. Objective: We aimed to estimate the social inequalities in health in Colombia, according to the type of affiliation to the health system as a proxy of socioeconomic status. Materials and methods: We conducted a retrospective descriptive analysis calculating incidence rates age and sex adjusted for all mandatory reporting events using the affiliation regime (subsidized and contributory) as a socioeconomic proxy. Estimates were made at departmental level for 2015. Social inequalities were calculated in terms of absolute and relative gaps. Results: We found social inequalities in the occurrence of mandatory reporting events in population affiliated to the Colombian subsidized regime (poor population). In this population, 82.31 cases of Plasmodium falciparum malaria per 100,000 affiliates were reported more than those reported in the contributory regime. Regarding the relative gap, belonging to the subsidized regime increased by 31.74 times the risk of dying from malnutrition in children under 5 years of age. Other events such as those related to sexual and reproductive health (maternal mortality, gestational syphilis and congenital syphilis); neglected diseases and communicable diseases related to poverty (leprosy and tuberculosis), also showed profound inequalities. Conclusion: In Colombia there are inequalities by regime of affiliation to the health system. Measured socioeconomic status was a predictor of increased morbidity and premature mortality.
Introducción. Las desigualdades en salud se generan por diferencias en las condiciones sociales y económicas, lo cual influye en el riesgo de enfermar y la forma de enfrentar la enfermedad. Objetivo. Evaluar las desigualdades sociales en salud en Colombia, utilizando el tipo de afiliación al sistema de salud como un parámetro representativo (proxy) de la condición socioeconómica. Materiales y métodos. Se trata de un análisis descriptivo y retrospectivo en el que se calcularon las tasas específicas de incidencia, ajustadas por edad y sexo, para eventos de notificación obligatoria, utilizando el régimen de afiliación (subsidiado o contributivo) como variable representativa del nivel socioeconómico. Las estimaciones se hicieron a nivel departamental para el 2015. Las desigualdades sociales se calcularon en términos de brechas absolutas y relativas. Resultados. Se evidencian desigualdades sociales en la ocurrencia de eventos de notificación obligatoria, las cuales desfavorecen a la población afiliada al régimen subsidiado. En esta población, se reportaron 82,31 casos más de malaria Plasmodium falciparum por 100.000 afiliados, que los notificados en el régimen contributivo. Respecto a la brecha relativa, el pertenecer al régimen subsidiado se asocia con un aumento de 31,74 veces del riesgo de morir por desnutrición en menores de cinco años. Otros eventos también presentaron profundas desigualdades, como los relacionados con la salud sexual y reproductiva (mortalidad materna, sífilis gestacional y sífilis congénita), las enfermedades infecciosas y las enfermedades transmisibles relacionadas con la pobreza (lepra y tuberculosis). Conclusión. El tipo de afiliación al Sistema General de Seguridad Social en Salud en Colombia es un buen indicador del nivel socioeconómico, y es un factor predictor de mayor morbilidad y mortalidad prematura asociada con los factores determinantes sociales de la salud.
Asunto(s)
Notificación de Enfermedades/estadística & datos numéricos , Disparidades en el Estado de Salud , Planes de Sistemas de Salud/estadística & datos numéricos , Disparidades en Atención de Salud/estadística & datos numéricos , Programas Nacionales de Salud/estadística & datos numéricos , Factores de Edad , Causas de Muerte , Colombia/epidemiología , Femenino , Humanos , Seguro de Salud/estadística & datos numéricos , Masculino , Notificación Obligatoria , Pacientes no Asegurados/estadística & datos numéricos , Estudios Retrospectivos , Factores Sexuales , Factores SocioeconómicosRESUMEN
INTRODUCTION: Pathological changes of preexisting sigma diverticulosis into a state of sigma diverticulitis are possible. Treatment of sigma diverticulitis accounts for a significant proportion of emergency treatments in clinics. The number of patients treated for sigma diverticulitis has risen steadily in recent years. Although it can be observed that operated cases making 7â% compared with 14â% to all stationary admissions, there is a less marked increase. Nevertheless, the question should be clarified as to how high the proportion of complicated surgical cases is in relation to non-complicated cases. It is important to clarify, in this context, if each operation is justified or whether in some cases there is over-treatment. MATERIAL AND METHODS: All data relating to Germany, were prospectively collected by the treating hospitals using the DRG and evaluated by the Federal Statistical Office. The treatment numbers from Erlangen were prospectively collected from the encrypted DRG and analysed retrospectively by the coding officer. The investigated period lasted from 2005 to 2010. To demonstrate some treatment options, the following possible forms of therapy were examined with reference to the Hansen/Stock classification. RESULTS: In Germany, about 40â% of stationary patients with sigma diverticulitis are treated surgically. It is striking that in about two thirds of all operated patients uncomplicated forms of diverticulitis were present. The remainder consisted of covered or free perforations. For these complicated forms, various treatment approaches have been established. Ultimately, in dependence of timing these are always surgically treated. In the milder forms the general indication for surgery has come into discussion as the recommendation for a surgical approach after the second relapse in the symptom-free interval is being questioned by several groups based on the age of the studies on which the recommendations are based. CONCLUSION: A significant increase in hospital admissions and surgically treated patients is demonstrated. Striking was that a closer analysis of data revealed that mainly non-complicated cases were surgically treated. This should be seen as a clear indication for an over-treatment. Therefore, possibly not all surgeries performed are justified. In the case of complicated forms, in consideration of various treatment paths, surgery is inevitable in most cases.
Asunto(s)
Diverticulitis del Colon/cirugía , Enfermedades del Sigmoide/diagnóstico , Enfermedades del Sigmoide/cirugía , Procedimientos Innecesarios , Estudios Transversales , Grupos Diagnósticos Relacionados , Diverticulitis del Colon/diagnóstico , Diverticulitis del Colon/epidemiología , Alemania , Perforación Intestinal/diagnóstico , Perforación Intestinal/epidemiología , Perforación Intestinal/cirugía , Programas Nacionales de Salud/estadística & datos numéricos , Admisión del Paciente/estadística & datos numéricos , Estudios Prospectivos , Enfermedades del Sigmoide/epidemiologíaRESUMEN
BACKGROUND: Burkina Faso achieved the leprosy elimination as a public health problem but this benefit was being lost. So, the National Program for Fighting against Leprosy has defined a strategy to reverse this situation. The aim of this survey was to evaluate the performance of the national program in the execution of this strategy in the region of "Hauts Bassins" (Burkina Faso) from 2005 to 2009. METHOD: The survey was led through the five sanitary districts of the region. It consisted in interview with the mean actors of leprosy control program and the analysis of the data notified on the leprosy cases, in order to estimate the progression of the key indicators of detection and follow-up care for patients having leprosy. RESULTS: During the survey period, 248 cases of leprosy were recorded including 236 new cases and 12 relapses. The prevalence of leprosy was 0.28 per 100 000 inhabitants in 2009. The detection rate decreased from 3.77 per 100 000 in 2005 to 2.75 per 100 000 in 2009. Among the 236 new cases of leprosy, 194 (82.2 %) were multibacillary form (MB). MB patients proportion increased from 69,3 % in 2005 to 91.1 % in 2009. The proportion of children was on average 3.8 %, the one of female cases 38.9 %. Newly diagnosed cases with grade 2 disabilities moved up from 21.4 % in 2005 to 42.2 % in 2009. The completion of cure rate was globally 88.26 %. The losts from follow-up among the patients who started multi-drug therapy were 7.14 %. CONCLUSION: The aim of the leprosy elimination as a public health problem is achieved but some challenges may be taken up, particularly in the organization of leprosy detection by the heath structures.
Asunto(s)
Promoción de la Salud/estadística & datos numéricos , Lepra/prevención & control , Programas Nacionales de Salud/estadística & datos numéricos , Adolescente , Adulto , Burkina Faso/epidemiología , Niño , Competencia Clínica , Notificación de Enfermedades , Femenino , Promoción de la Salud/economía , Promoción de la Salud/organización & administración , Encuestas Epidemiológicas , Humanos , Leprostáticos/economía , Leprostáticos/provisión & distribución , Leprostáticos/uso terapéutico , Lepra/diagnóstico , Lepra/tratamiento farmacológico , Lepra/economía , Lepra/epidemiología , Lepra Multibacilar/diagnóstico , Lepra Multibacilar/tratamiento farmacológico , Lepra Multibacilar/economía , Lepra Multibacilar/epidemiología , Masculino , Persona de Mediana Edad , Morbilidad/tendencias , Programas Nacionales de Salud/economía , Programas Nacionales de Salud/organización & administración , Prevalencia , Evaluación de Programas y Proyectos de Salud , Recurrencia , Resultado del Tratamiento , Adulto JovenRESUMEN
INTRODUCTION: Leprosy is a chronic and complex infectious illness; the new-case detection rate is better than prevalence as an indicator of disease trends. This study presents an analysis of pattern of new cases of leprosy detected annually from 2004 to 2008 in Sohag Governorate, Upper Egypt. PATIENTS AND METHODS: Data about patients with newly diagnosed leprosy were collected from Sohag leprosy hospital, the main referral centre in the governorate. Case detection rates (CDR) were calculated for each year by dividing the newly diagnosed cases by mid-year populations for the same year. RESULTS: 587 patients were newly diagnosed between 2004 and 2008. The mean age of patients at diagnosis was 34 years, 62% were males, and 11% were children below 15 years of age. The overall leprosy case detection rate was 3-1/100,000 population and it decreased from 3.4/100,000 population in 2004 to 2.8/100,000 population in 2008. Ninety three percent were classified as multibacillary, and 20.4% had Grade 2 disability at diagnosis. CONCLUSIONS: Leprosy remains a health problem in Sohag Governorate. It is possible that new cases are being detected late owing to inadequate community awareness of the disease. Leprosy control activities should be provided in primary health care units in order to detect new cases, and continued surveillance is required to detect relapses and to ensure good patient compliance with treatment.
Asunto(s)
Control de Enfermedades Transmisibles/tendencias , Evaluación de la Discapacidad , Lepra/diagnóstico , Adolescente , Adulto , Niño , Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/estadística & datos numéricos , Recolección de Datos/métodos , Diagnóstico Tardío/estadística & datos numéricos , Niños con Discapacidad , Personas con Discapacidad , Egipto/epidemiología , Femenino , Educación en Salud/estadística & datos numéricos , Hospitales/estadística & datos numéricos , Humanos , Lepra/tratamiento farmacológico , Lepra/epidemiología , Lepra/patología , Masculino , Persona de Mediana Edad , Programas Nacionales de Salud/estadística & datos numéricos , Índice de Severidad de la Enfermedad , Adulto JovenAsunto(s)
Leprostáticos/uso terapéutico , Lepra/tratamiento farmacológico , Lepra/epidemiología , Programas Nacionales de Salud/estadística & datos numéricos , Programas Nacionales de Salud/tendencias , Distribución por Edad , Control de Enfermedades Transmisibles/métodos , Control de Enfermedades Transmisibles/tendencias , Quimioterapia Combinada , Femenino , Humanos , Incidencia , India/epidemiología , Lepra/mortalidad , Masculino , Prevalencia , Distribución por Sexo , Resultado del TratamientoAsunto(s)
Control de Enfermedades Transmisibles/tendencias , Encuestas Epidemiológicas , Hospitales/tendencias , Leprostáticos/uso terapéutico , Lepra/epidemiología , Programas Nacionales de Salud/tendencias , Distribución por Edad , Control de Enfermedades Transmisibles/estadística & datos numéricos , Femenino , Hospitales/estadística & datos numéricos , Humanos , Incidencia , India/epidemiología , Lepra/tratamiento farmacológico , Lepra/mortalidad , Masculino , Programas Nacionales de Salud/estadística & datos numéricos , Prevalencia , Distribución por SexoRESUMEN
An impressive decline in leprosy prevalence rate (PR) in all endemic districts of India is seen in the post-MDT era. However, the new case-detection rate, an important statistical indicator in leprosy control programmes, has not shown significant decline in spite of all efforts. In Himachal Pradesh, a decline in PR from 7.8 to 0.56/10000 between 1991 to 2000 is seen, and recently the State has won national acclaim for having achieved the goal of elimination of leprosy in all the districts. The vertical leprosy programme has been integrated into general health services of the state. An analysis of data from 1991 to 2000 of two leprosy control units of Himachal Pradesh, the Urban Leprosy Clinic in Shimla (ULC-S) and the District Leprosy Control Unit in Mandi (DLCU-M), showed no significant decline in the new cases detected. 277 and 271 new cases were detected at these centres respectively; these included 2.2% and 1.5% children of less than 14 years of age. Almost 75% of these cases were males and of MB type. A steadily increasing trend in the annual detection of new cases was seen at both the centres during the decade. The cases registered at DLCU-M were mainly indigenous to the district. At ULC-S, 45 migrant cases from other endemic areas-mainly from Nepal, Bihar, and Uttar Pradesh-had also contributed to the increased number of new cases. Other possible causes discussed for this higher new case detection, e.g. overdiagnosis, detection of backlog "hidden cases" and voluntary reporting of patients, do not differ from those seen in other parts of the country or the world.
Asunto(s)
Control de Enfermedades Transmisibles/tendencias , Lepra/diagnóstico , Lepra/epidemiología , Programas Nacionales de Salud/estadística & datos numéricos , Adolescente , Distribución por Edad , Anciano , Niño , Preescolar , Control de Enfermedades Transmisibles/métodos , Quimioterapia Combinada , Femenino , Humanos , Incidencia , India/epidemiología , Leprostáticos/uso terapéutico , Lepra/prevención & control , Masculino , Persona de Mediana Edad , Prevalencia , Distribución por SexoRESUMEN
Based upon the data from the Chinese National System for Leprosy Surveillance, this paper reports on the relapses in 297,343 leprosy patients [multibacillary (MB) 106,518, paucibacillary (PB) 190,825] cured by dapsone monotherapy. A total of 11,055 (MB 8675, PB 2380) patients relapsed during an accumulated follow-up period of 4,229,050 patient-years (PY), giving an overall relapse rate of 3.72 per 100 cases or 2.61 per 1000 PY, i.e., 8.14% or 5.91 per 1000 PY over an average follow-up period of 13.8 +/- 8.4 years in MB patients and 1.25% or 0.86 per 1000 PY over an average period of 14.5 +/- 8.9 years in PB patients. For either the overall relapse rate per 100 cases or per 1000 PY, the differences between MB and PB patients were statistically significant, except during 36-40 years of follow up. For both MB and PB patients, the relapse rates showed consistently significant decreases year by year, particularly in PB patients whose relapse rate per 1000 PY was 1.21 in year 10 of follow up; whereas it remained more than 10 per 1000 PY in MB patients. In view of that, the overall relapse rates in MB and PB patients cured by dapsone monotherapy were acceptably low, and most of these patients have been followed up for more than a mean incubation period of observed dapsone relapse. Along with the further extension of follow up, the risk of relapse in dapsone-cured patients will not be expected to increase. This conclusion should be considered when planning policy for the management of patients released from dapsone monotherapy.
Asunto(s)
Dapsona/uso terapéutico , Leprostáticos/uso terapéutico , Lepra/tratamiento farmacológico , Lepra/prevención & control , Programas Nacionales de Salud/estadística & datos numéricos , Vigilancia de la Población , China , Estudios de Seguimiento , Humanos , Recurrencia , Estudios Retrospectivos , Factores de Riesgo , Factores de TiempoRESUMEN
Based upon the data from the Chinese National System for Leprosy Surveillance, this paper reports on the relapses in 47,276 leprosy patients cured by or released from WHO-recommended multidrug therapy (WHO/MDT). The overall relapse rate was 0.73/1000 patient-years (PY). There was a statistically significant difference in the relapse rates of WHO/MDT-MB (0.61/1000 PY) and WHO/MDT-PB (1.04/1000 PY) (chi 2 = 15.7, p < 0.01) patients. For multibacillary (MB) patients, the relapse rate in patients treated with fixed-duration MDT (0.56/1000 PY) was comparable with that in patients treated with MDT until skin-smear negativity (0.73/1000 PY) (chi 2 = 2.20, p > 0.05). Our present study suggests that fixed-duration MDT is a cost-effective regimen for the treatment of leprosy in China. The present results also show that relapse of leprosy is acceptably low and has not yet become a serious clinical or public health problem but, based upon the incubation of relapse in MDT patients, it is necessary to encourage annual follow up for at least 5 years for paucibacillary (PB) and 10 years for MB patients after being released from WHO/MDT.
Asunto(s)
Leprostáticos/uso terapéutico , Lepra/tratamiento farmacológico , Lepra/prevención & control , Programas Nacionales de Salud/estadística & datos numéricos , China , Quimioterapia Combinada , Estudios de Seguimiento , Humanos , Recurrencia , Factores de Riesgo , Organización Mundial de la SaludRESUMEN
National sanatoria for Hansen's disease in Japan were special institutions that only treated in-patients. But a few sanatoria for Hansen's disease located in islands and rural districts should have other duty, namely service to community health because there was no other clinic office. New patients with Hansen's disease are very small in number and inpatients become older and older. Then the new role should be seeked to National sanatoria for Hansen's disease in Japan. Amami-wakoen, National sanatorium for Hansen's disease in Amami island started skin clinic for out-patients with skin diseases in March, 1983 because there were few skin clinics in Amami district. The number of patients with skin diseases increases year by year (from 12.3 persons every day in 1983 to 36.4 in 1989). We surveyed receipts of National health insurance for the purpose of studying the main diseases in Amami main island and the behavior of the patients with skin diseases. The results of survey are followings; 1. The percentage of patients with skin diseases in Amami main island in August, 1987 was significantly superior. 2. The percentage of patients with mental diseases and pregnant woman in hospital and patients with gastrointestinal disorders and pregnant women in clinic were significantly large in May, 1987 in Amami main island. 3. There was a tendency that the patients with skin diseases visited to the clinic near in place. It was found that we treated only 5.1 percent persons of patients with skin diseases in August, 1987.
Asunto(s)
Servicios de Salud Comunitaria , Colonias de Leprosos , Lepra , Programas Nacionales de Salud/estadística & datos numéricos , Femenino , Enfermedades Gastrointestinales/epidemiología , Humanos , Japón/epidemiología , Trastornos Mentales/epidemiología , Aisladores de Pacientes , Embarazo , Enfermedades de la Piel/epidemiologíaRESUMEN
La lepra es un padecimiento tradicionalmente considerado del medio rural, y es en este medio que en 1927 se realizó el primer censo de enfermos de lepra que clasificó 1,450 casos: Jalisco 237 casos. Distrito Federal 225, Michoacán 165, Sinaloa 144. Los enfermos del D.F. procedían en su mayoría de los estados migrando en busca de mejor atención médica. A partir de 1960 inician actividades de búsqueda intensiva de casos en el área identificada como altamente endémica, en el período 1960-1970 fueron notificados 11,073 casos, 63//de ellos detectados en el área rural. En la década de los 70s se detectaron 6,947 enfermos y de 1980 a 1990 se notificaron 4,095 enfermos nuevos. El promedio de incidencias en el medio rural oscila (de 1940 a 1990) entre el 60//y 66//. Acciones contra la lepra en el medio rural (1920 a 1989): inicialmente el enfermo tenía que acudir a las ciudades a atenderse; en 1930 se promulgó el Reglamento Federal de Profilaxis de la Lepra, instalando juntas centrales de profilaxis en 28 estados, además de 238 juntas municipales. Para 1960 se reestructura el reglamento y se crea el Programa Nacional para el Control de las Enfermedades Crónicas de la Piel y para los 80s se introducen cambios en el manejo de la enfermedad, se ejecutó la descentralización y se emplean nuevos medicamentos politerápicos con rifampicina, clofazimina y D.D.S